• CONTACT
  • MARKETCAP
  • BLOG
Coin Mela Coin Mela
  • Home
  • News
    • All News
    • Bitcoin
    • Ethereum
    • XRP
    • Altcoins
    • NFT
    • Blockchain
    • Web3
    • DeFi
    • Finance
    • Stocks
    • Company
  • Learn
  • Market
  • Advertise
Reading: Investing in Dividend ETFs: Why the Schwab U.S. Dividend Equity ETF is Best for 2025
Share
  • bitcoinBitcoin(BTC)$91,365.00
  • ethereumEthereum(ETH)$3,138.42
  • tetherTether(USDT)$1.00
  • rippleXRP(XRP)$2.09
  • binancecoinBNB(BNB)$902.96
  • usd-coinUSDC(USDC)$1.00
  • solanaSolana(SOL)$135.72
  • tronTRON(TRX)$0.287685
  • staked-etherLido Staked Ether(STETH)$3,134.10
  • dogecoinDogecoin(DOGE)$0.141820
CoinMelaCoinMela
Font ResizerAa
  • Home
  • News
  • Learn
  • Market
  • Advertise
Search
  • Home
  • News
    • All News
    • Bitcoin
    • Ethereum
    • XRP
    • Altcoins
    • NFT
    • Blockchain
    • Web3
    • DeFi
    • Finance
    • Stocks
    • Company
  • Learn
  • Market
  • Advertise
Have an existing account? Sign In
Follow US
© Coin Mela Network. All Rights Reserved.
Finance

Investing in Dividend ETFs: Why the Schwab U.S. Dividend Equity ETF is Best for 2025

News Desk
Last updated: September 28, 2025 10:08 pm
News Desk
Published: September 28, 2025
Share
gettyimages 589970802

For income investors seeking reliable returns, dividend exchange-traded funds (ETFs) present an attractive opportunity. Unlike individual dividend stocks, which can be challenging to select and track, dividend ETFs provide the advantages of dividends along with the benefits of diversification. This is especially beneficial in today’s market, where pinpointing standout stocks for long-term growth can be daunting. High-growth options like Nvidia, for instance, may offer impressive returns but provide minimal payouts, often not justifying the investment for income-focused investors.

Among the plethora of dividend ETFs available, the Schwab U.S. Dividend Equity ETF (SCHD) emerges as a top choice for 2025. Managed by Charles Schwab Asset Management, this ETF tracks the Dow Jones U.S. Dividend 100 Index, targeting companies with a solid history of paying dividends. Stocks included in this fund are chosen based on their superior fundamentals, ensuring investors can access quality holdings.

One of the ETF’s most appealing features is its low expense ratio of just 0.06%, translating to annual fees of only $6 for every $10,000 invested. This affordability, combined with substantial total net assets of $71 billion, provides a solid foundation for potential investors. The ETF’s holdings are heavily weighted toward sectors known for consistent dividend payouts, such as healthcare, consumer goods, industrials, and energy.

The top ten holdings of SCHD reflect this strategic focus:
– AbbVie: 4.22% portfolio weight, 3.0% dividend yield (Healthcare)
– ConocoPhillips: 4.10% portfolio weight, 3.3% dividend yield (Energy)
– Chevron: 4.09% portfolio weight, 4.3% dividend yield (Energy)
– Home Depot: 4.08% portfolio weight, 2.2% dividend yield (Consumer cyclical)
– Lockheed Martin: 4.08% portfolio weight, 2.7% dividend yield (Industrial)
– Cisco Systems: 4.04% portfolio weight, 2.4% dividend yield (Technology)
– Verizon Communications: 4.01% portfolio weight, 6.4% dividend yield (Communication services)
– Amgen: 3.99% portfolio weight, 3.4% dividend yield (Healthcare)
– Altria Group: 3.97% portfolio weight, 6.5% dividend yield (Consumer defensive)
– Coca-Cola: 3.91% portfolio weight, 3.1% dividend yield (Consumer defensive)

While the ETF maintains a consistent payout schedule, the actual amounts may fluctuate based on the varying dividend schedules of the underlying companies. This variability is an important consideration for investors relying on predictable income streams.

The SCHD ETF’s attractiveness is further enhanced by its competitive yield. It differentiates itself from other funds — for example, the Vanguard High Dividend Yield Index Fund ETF yields more than a full percentage point lower, while broader index funds such as the Vanguard Value Index Fund ETF and the Invesco QQQ Trust offer yields of around 2.1% and 0.5%, respectively.

Despite its strengths, one potential drawback of the SCHD ETF is its limited exposure to the technology sector, which has been the standout performer in recent years. Although SCHD includes some notable tech companies, many tech giants that are leading growth do not offer dividends, thus limiting their inclusion.

For investors primarily focused on generating income through dividends, the SCHD ETF represents a compelling option and could well serve as a key holding in a diversified portfolio. However, those interested in capitalizing on emerging trends, such as advancements in artificial intelligence, may also want to consider allocating funds to technology-focused ETFs or individual stocks in that sector to achieve a more balanced investment strategy.

Telecommunications Issue Causes Flight Delays at Dallas-Fort Worth Airports
Mixed Trading on Wall Street as Markets Anticipate Federal Reserve’s Interest Rate Decision
Stock Futures Rise on Hopes of Federal Reserve Rate Cut After Weak Retail Sales Data
Gold Price Consolidates Ahead of US Inflation Data and Fed Rate Decision
Indian Tech Stocks Plunge Following $100,000 H-1B Visa Fee Announcement
Share This Article
Facebook Whatsapp Whatsapp
ByNews Desk
Follow:
CoinMela News Desk brings you the latest updates, insights, and in-depth coverage from the world of cryptocurrencies, blockchain, and digital finance.
Previous Article 01999200 ce73 7773 ba8e 0a694c803cbc Bitcoin Advocates Claim Cryptocurrency Could Reduce Warfare by Curbing Government Currency Printing
Next Article Crypto com Secures U S CFTC and NFA Approvals for Derivatives Expansion Crypto.com Secures Major U.S. Regulatory Approvals to Expand Derivatives Operations
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
353e38c56b572ac874fd8ad4f8da77b6
Cboe Global Markets: Analyzing Valuation Amid Cooling Momentum
1765136159 0x0
Bitcoin’s Surge Stalls Amid SEC Chair’s Blockchain Prediction and Market Concerns
gettyimages 2249273085
Trump Administration Appoints Vaccine Skeptic to Lead FDA’s Drug Evaluation Office, Raising Concerns Among Officials
- Advertisement -
Ad image

Follow Us on Socials

We use social media to react to breaking news, update supporters and share information

Twitter Youtube Telegram Linkedin
Coin Mela Coin Mela
CoinMela is your one-stop destination for everything Crypto, Web3, and DeFi news.
  • About Us
  • Contact Us
  • Corrections
  • Terms and Conditions
  • Disclaimer
  • Privacy Policy
  • Advertise with Us
  • Quick Links
  • Finance
  • Company
  • Stocks
  • Bitcoin
  • News
  • XRP
  • Ethereum
  • Altcoins
  • Blockchain
  • DeFi
© Coin Mela Network. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?